IRCT20181113041641N2
Complementary Medicine in Multiple Sclerosis
Effects of Dietary Modification Based on Complementary and Alternative Iranian Medicine in Patients with Secondary-Progressive Multiple Sclerosis
Artesh University of Medical Sciences·Phase 3·Iranian Registry Of Clinical TrialCompleted
Study focus
- Disease/Condition
- Multiple sclerosis
- Study type
- Interventional
Sponsor & location
- Primary sponsor
- Artesh University of Medical Sciences
- Location
- Iran
Timeline & enrollment
- Phase
- Phase 3
- Start date
- Aug 22, 2022
- End date
- N/A
ICD-10 classifications
Multiple sclerosisProgressive systemic sclerosisSystemic sclerosisSystemic sclerosis, unspecifiedDiffuse sclerosis
Data source
- Registry
- Iranian Registry Of Clinical Trial
- Trial ID
- IRCT20181113041641N2
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for IRCT20181113041641N2 through Pure Global AI's free database. This Phase 3 trial is sponsored by Artesh University of Medical Sciences and is currently Completed. The study focuses on Multiple sclerosis.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.